InMode (INMD) Free Cash Flow Growth (1y) (2019 - 2026)
InMode (INMD) Free Cash Flow Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | 28.87% |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 14.12% |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 0.77% |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 13.29% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 142.84% |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | -11.68% |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 750.00% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 0.40% |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | -14.34% |
| 10 | InMode | 910.68 Mn | 495.51 Mn | 71.52 Mn | -12.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.11% |
| Dec 31, 2025 | -28.98% |
| Sep 30, 2025 | -27.91% |
| Jun 30, 2025 | -42.58% |
| Mar 31, 2025 | -41.68% |
| Dec 31, 2024 | -46.60% |
| Sep 30, 2024 | -17.95% |
| Jun 30, 2024 | -20.47% |
| Mar 31, 2024 | 12.92% |
| Dec 31, 2023 | 6.45% |
| Sep 30, 2023 | -9.54% |
| Jun 30, 2023 | 11.89% |
| Mar 31, 2023 | -33.27% |
| Dec 31, 2022 | 8.30% |
| Sep 30, 2022 | -9.36% |
| Jun 30, 2022 | 0.96% |
| Mar 31, 2022 | 28.96% |
| Dec 31, 2021 | 27.52% |
| Sep 30, 2021 | 67.43% |
| Jun 30, 2021 | 2,938.13% |